21 Feb 2018
// PRESS RELEASE
24 Oct 2017
// PRESS RELEASE
Latest Content by PharmaCompass
Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.
About
Industry Trade Show
Not Confirmed
17-20 March, 2025
Antibody EngineeringAntibody Engineering
Industry Trade Show
Not Confirmed
15-19 December, 2024
Pharma, Lab & Chemical...Pharma, Lab & Chemical Expo
Industry Trade Show
Not Confirmed
03-05 January, 2025
CONTACT DETAILS
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
17-20 March, 2025
Antibody EngineeringAntibody Engineering
Industry Trade Show
Not Confirmed
15-19 December, 2024
Pharma, Lab & Chemical...Pharma, Lab & Chemical Expo
Industry Trade Show
Not Confirmed
03-05 January, 2025
CORPORATE CONTENT #SupplierSpotlight
21 Feb 2018
// PRESS RELEASE
https://www.globenewswire.com/en/news-release/2018/02/21/1372801/36477/en/Mission-Pharmacal-enters-into-agreement-with-MainPointe-Pharmaceuticals-to-purchase-and-license-Mission-s-consumer-products.html#:~:text=SAN%20ANTONIO%2C%20Feb.,licensed%20by%20Mission%20to%20MainPointe.
24 Oct 2017
// PRESS RELEASE
https://www.missionpharmacal.com/press-release/mission-pharmacal-general-counsel-gains-national-recognition-innovative-ethics
https://www.prnewswire.com/news-releases/fewer-than-half-of-us-women-take-recommended-vitamins-prior-to-pregnancy-according-to-march-of-dimes-new-prenatal-health--nutrition-survey-300521234.html
22 Aug 2017
// DRUGSTORENEWS
https://drugstorenews.com/pharmacy/mission-pharmacal-extends-product-lines
09 Feb 2017
// YAHOO
https://finance.yahoo.com/news/mission-pharmacal-announces-continued-support-211325031.html
24 Jan 2017
// YAHOO
https://finance.yahoo.com/news/mission-pharmacal-invests-elements-genius-190000040.html
RLD : Yes
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : LITHOSTAT
Dosage Strength : 250MG
Approval Date : 1983-05-31
Application Number : 18749
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : No
TE Code : AA
Dosage Form : TABLET; ORAL
Proprietary Name : CARBINOXAMINE MALEATE
Dosage Strength : 4MG
Approval Date : 2011-05-27
Application Number : 90756
RX/OTC/DISCN : RX
RLD : No
TE Code : AA
RLD : No
TE Code :
Dosage Form : POWDER; ORAL
Proprietary Name : CALCIBIND
Dosage Strength : 2.5GM/PACKET
Approval Date : 1982-12-28
Application Number : 18757
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Dosage Form : POWDER; ORAL
Proprietary Name : CALCIBIND
Dosage Strength : 300GM/BOT
Approval Date : 1984-10-16
Application Number : 18757
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : FOLICET
Dosage Strength : 1MG
Approval Date : 1982-01-01
Application Number : 87438
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code : AA
Dosage Form : SOLUTION; ORAL
Proprietary Name : GABAPENTIN
Dosage Strength : 250MG/5ML
Approval Date : 2011-02-18
Application Number : 78974
RX/OTC/DISCN : RX
RLD : No
TE Code : AA
RLD : No
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : HOMAPIN-10
Dosage Strength : 10MG
Approval Date : 1982-01-01
Application Number : 86308
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : HOMAPIN-5
Dosage Strength : 5MG
Approval Date : 1982-01-01
Application Number : 86309
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Dosage Form : TABLET, CHEWABLE; ORAL
Proprietary Name : EQUIPIN
Dosage Strength : 3MG
Approval Date : 1982-01-01
Application Number : 86310
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Dosage Form : SOLUTION; TOPICAL
Proprietary Name : TEXACORT
Dosage Strength : 1%
Approval Date : 1982-01-01
Application Number : 80425
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Services
Analytical
Drug Product Manufacturing
API & Drug Product Development
Pharma Service : API & Drug Product Development
Category : Formulation Development
Sub Category : Process Development & Optimization
Pharma Service : API & Drug Product Development
Pharma Service : API & Drug Product Development
Category : Formulation Development
Sub Category : Tablet
Pharma Service : API & Drug Product Development
Pharma Service : API & Drug Product Development
Category : Formulation Development
Sub Category : Topical
Pharma Service : API & Drug Product Development
Pharma Service : API & Drug Product Development
Category : Formulation Development
Sub Category : Liquid Formulation
Pharma Service : API & Drug Product Development
Pharma Service : API & Drug Product Development
Category : Formulation Development
Sub Category : Controlled / Immediate / Modified Release
Pharma Service : API & Drug Product Development
Pharma Service : API & Drug Product Development
Category : Formulation Development
Sub Category : Cream / Gel / Lotion / Ointment
Pharma Service : API & Drug Product Development
Pharma Service : API & Drug Product Development
Category : Formulation Development
Sub Category : Clinical Supply
Pharma Service : API & Drug Product Development
Pharma Service : API & Drug Product Development
Category : Formulation Development
Sub Category : Scale-Up Capabilities
Pharma Service : API & Drug Product Development
Pharma Service : API & Drug Product Development
Category : Formulation Development
Sub Category : Tech Transfer
Pharma Service : API & Drug Product Development
Packaging
Inspections and registrations
Type : GMP Certificates
Number : ES/017/USA
EudraGMDP Key : 19257
Country : U.S.A
Issue Date : 2013-06-06
Post Code :
NCA Ref : 165911370856...
City : TX 78006
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?